NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nami Surgical

Nami Surgical

Private
GlasgowHealthcare & Life Scienceshttps://www.namisurgical.com/

Last Round

Early Funding

Jan 28, 2026

Total Funding Raised

$3.53M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Nami Surgical is a medical technology company that develops high-performance miniaturised ultrasonic scalpels for robotic-assisted surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

robotic surgeryultrasonic scalpelsurgical roboticsmedtechrobotic-assisted surgerysurgical instrumentstissue cuttingcoagulationmedical devicerobot-assisted surgerysurgical techultrasonic technologysurgical hardwareOEM integration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nami Surgical Comps

Public and private peers based on sector, stage, and business model.

Nami Surgical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nami Surgical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJan 28, 2026
Series AAug 19, 2025
GrantMay 8, 2024

Key People

Founding team and executive leadership

Rebecca Shirley Cleary

Co-Founder And CTO

Founding Team

Nico Fenu

Chief Executive Officer, Founder And Director

Founding Team

Nikki Palfrey

Chief Executive Officer, Non Executive Director

Executive Team

Nami Surgical Investors

Notable investors and investment history

Nami Surgical investors
InvestorRounds
British Business BankGrant, Early Funding
Innovate UKGrant
Eos AdvisoryGrant, Early Funding
Social Investment Scotland (SIS) VenturesGrant
Scottish Investment Bank (Scottish Enterprise)Grant, Early Funding
Easton CapitalEarly Funding
SIS VenturesGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 29, 2026

    Nikki Palfrey named new Chief Executive Officer.

  • Mar 6, 2025

    David O'Reilly joins as corporate strategy advisor.

Nami Surgical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nami Surgical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nami Surgical's valuation, stock price, and market status.

Firmographic Details

HeadquartersGlasgow
Employee Range19
Year Founded2021
Last FundingJan 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.